EN Hikma Analyst coverage The following table includes the names of sell-side analysts that regularly publish research reports on Hikma. Institution Analyst Email address Phone number BAML Patrick Wood patrick.wood@bofa.com +44 (0) 20 7995 7035 Barclays Rosie Turner rosie.turner@barclays.com +44 (0) 203 134 8680 Citi Peter Verdult peter.verdult@citi.com +44 (0) 207 986 4164 Goldman Sachs Keyur Parekh Keyur.Parekh@gs.com Jefferies James Vane-Tempest jvane-tempest@jefferies.com JP Morgan James Gordon james.d.gordon@jpmorgan.com Morgan Stanley Thibault Boutherin thibault.boutherin@morganstanley.com +44 (0) 20 7425 9688 Numis Paul Cuddon p.cuddon@numis.com +44 (0) 20 7260 1299 Peel Hunt Amy Walker amy.walker@peelhunt.com Stifel Max Hermann +44 (0) 20 7710 7606 This list is provided for informational purposes only and any opinions, estimates, forecasts, predictions, conclusions, recommendations or other statements regarding the performance of Hikma made by these analysts are theirs alone and do not constitute the opinions, estimates, forecasts, predictions, conclusions, recommendations or statements of any member of Hikma or any of its Directors, employees or agents. Analyst estimates Investors Analyst coverage Back to top Useful links About Products Investors News Careers Contact Worldwide Leadership Stay in touch Subscribe to our newsletter Follow us instagram Created with Sketch. © Hikma Pharmaceuticals PLC 2021 Terms of use Cookie policy Disclaimer Privacy policy Community guidelines Our website uses cookies to improve your experience. Some of the cookies we use are essential for parts of our website to operate. By using our website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

EN Hikma Regulatory news Click here for news with inside information See more Investors Regulatory news Back to top Useful links About Products Investors News Careers Contact Worldwide Leadership Stay in touch Subscribe to our newsletter Follow us instagram Created with Sketch. © Hikma Pharmaceuticals PLC 2021 Terms of use Cookie policy Disclaimer Privacy policy Community guidelines Our website uses cookies to improve your experience. Some of the cookies we use are essential for parts of our website to operate. By using our website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.